Urinary and plasma vitamin D3 metabolites in the nephrotic syndrome

P. W. Lambert, P. B. De Oreo, I. Y. Fu, D. M. Kaetzel, K. von Ahn, B. W. Hollis, B. A. Roos

Research output: Contribution to journalArticlepeer-review

24 Scopus citations


Using newly developed and established extraction, Lipidex-5000 chromatography, normal phase gradient HPLC, and ligand binding assay techniques we have directly measured plasma and urine levels of vitamin D3 and its metabolites in seven normal subjects and seven patients with nephrotic syndrome and normal renal function. Significant reductions in the plasma levels of vitamin D,, 24,25(OH)2D3, 25,26(OH)2D,, and 1,25(OH)2D, were noted in all nephrotic patients. In conjunction with the plasma metabolite abnormalities, direct quantitative analysis of the urine in these patients revealed significant increases in nonconjugated 250HD,, 24,25(OH)2D3, and 1,25(OH)2D,. Significant correlations were noted between the plasma and/or urine metabolites and other mineral homeostatic parameters. The results indicate that the primary basis for the reductions in plasma vitamin D, and its metabolites in the nephrotic syndrome is enhanced urinary excretion. The findings of normal serum ionized Ca and i-PTH levels in the patients with nephrosis suggest that reductions in bound and not free forms of vitamin D3 metabolites in plasma may occur in the initial stages of the nephrotic syndrome.

Original languageEnglish (US)
Pages (from-to)7-15
Number of pages9
JournalMetabolic Bone Disease and Related Research
Issue number1
StatePublished - 1982


  • Nephrotic Syndrome
  • Vitamin D Metabolites

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Surgery


Dive into the research topics of 'Urinary and plasma vitamin D<sub>3</sub> metabolites in the nephrotic syndrome'. Together they form a unique fingerprint.

Cite this